According to recent reports in the international diabetes news, research teams have found a treatment that dampens the immune system and stops it from destroying pancreatic beta cells – the cause of type 1 diabetes . The drug could now have a role to play in preventing and even reversing type 1 diabetes .
The drug, which is called Imantinib or branded as Gleevec, is used to inhibit cell mutation amongst patients with chronic leukaemia. Fresh University of California research have shown that the drug substantially reduces diabetes amongst mice.
The team tested mice with Imantinib, and found that 80 per cent of mice experienced remission in their diabetes . The researchers concluded that the same drugs could be used to treat type 1 diabetes and perhaps even other auto-immune diseases.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…